SCHEMBL3103196

SCHEMBL3103196

Cc1ccccc1-c1ccnc(N)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 2/20 0.56
HSP90AA1 P07900 2/20 0.56
AURKA O14965 1/20 0.56
ADORA2A P29274 1/20 0.56
JAK2 O60674 3/20 0.54
DYRK1A Q13627 5/20 0.51
GSK3B P49841 4/20 0.51
CDK5 Q00535 4/20 0.51
CDK5R1 Q15078 3/20 0.51
CLK1 P49759 2/20 0.51
MAP3K14 Q99558 1/20 0.51
ROCK1 Q13464 2/20 0.49
CDK2 P24941 4/20 0.48
CDK4 P11802 2/20 0.48
CCNE1 P24864 1/20 0.47
FEN1 P39748 1/20 0.47
NFATC1 O95644 1/20 0.47
PTPN1 P18031 1/20 0.47
JAK3 P52333 2/20 0.46
PDPK1 O15530 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3393995 0.81 HSP90AA1 (0.55) PRKACAHSP90AA1AURKAADORA2AJAK2
SCHEMBL13723846 0.81 CYP1A2 (0.46) DYRK1ACDK2PTPN1MAPK1KDM4E
SCHEMBL30046927 0.81 HSP90AA1 (0.60) PRKACAHSP90AA1AURKAADORA2ADYRK1A
SCHEMBL18130895 0.81 HSP90AA1 (0.60) PRKACAHSP90AA1AURKAADORA2ADYRK1A
SCHEMBL10915242 0.80 CDK5 (0.53) PRKACAHSP90AA1AURKAADORA2ADYRK1A
SCHEMBL28098065 0.79 CDK2 (0.47) PRKACAHSP90AA1AURKAADORA2AJAK2
SCHEMBL30507532 0.78 CDK1 (0.57) PRKACAHSP90AA1AURKAADORA2ADYRK1A
SCHEMBL1914955 0.78 HSP90AA1 (0.59) PRKACAHSP90AA1AURKAADORA2AJAK2
SCHEMBL30353577 0.78 FEN1 (0.57) PRKACAHSP90AA1AURKAADORA2ADYRK1A
SCHEMBL5140478 0.78 FEN1 (0.57) PRKACAHSP90AA1AURKAADORA2ADYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107721991-B A kind of 6- (pyrimidine-4-yl) -1H- indazole derivative and its preparation method and application 南方医科大学中西医结合医院 2019-10-18 CN claimed
CN-107721991-A A kind of 6 (base of pyrimidine 4) 1H indazole derivatives and its preparation method and application 南方医科大学中西医结合医院 2018-02-23 CN claimed
CN-102356075-A Compositions and methods for inhibition of the jak pathway RIGEL PHARMACEUTICALS INC 2012-02-15 CN claimed
CN-112010844-B Preparation method and application of N- (pyrimidine-2-yl) coumarin-7-amine derivative as protein kinase inhibitor 中国药科大学 2023-07-25 CN disclosed
CN-112010844-A Preparation method and application of N- (pyrimidine-2-yl) coumarin-7-amine derivative as protein kinase inhibitor 中国药科大学 2020-12-01 CN disclosed
CN-107721991-B A kind of 6- (pyrimidine-4-yl) -1H- indazole derivative and its preparation method and application 南方医科大学中西医结合医院 2019-10-18 CN disclosed
CN-107721991-A A kind of 6 (base of pyrimidine 4) 1H indazole derivatives and its preparation method and application 南方医科大学中西医结合医院 2018-02-23 CN disclosed
CN-102356075-A Compositions and methods for inhibition of the jak pathway RIGEL PHARMACEUTICALS INC 2012-02-15 CN disclosed
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed
EP-2166858-A1 NOVEL HETEROCYCLE COMPOUNDS AND USES THEREOF Intra-Cellular Therapies, Inc. (US) 2010-03-31 EP disclosed
EP-2044061-A2 BENZOTHIOPHENE INHIBITORS OF RHO KINASE Kahraman, Mehmet (US) 2009-04-08 EP disclosed
WO-2008153959-A1 NOVEL HETEROCYCLE COMPOUNDS AND USES THEREOF INTRA-CELLULAR THERAPIES, INC. (US) 2008-12-18 WO disclosed
WO-2008011560-A2 BENZOTHIOPHENE INHIBITORS OF RHO KINASE KAHRAMAN MEHMET (US) 2008-01-24 WO disclosed